Heavy menstrual bleeding is common in women world wide. Management of bleeding has included oral tranexamic acid.
In the study of women aged 15 to 49 years, the association between use of oral tranexamic acid and the risk of venous thromboembolism and arterial thrombosis was examined. Venous thromboembolism and arterial thrombosis means the presence of blood clots in the circulatory system of the body.
Oral tranexamic acid has been given to women with heavy menstrual bleeding. This medication is effective as a temporary measure in both acute and as intermittent treatment of heavy menstrual bleeding. Typically, this medicine is given for 5 days.
The study concluded that even though there is a small risk of venous thromboembolic, the risk is low when used for short term, intermittent care in women who are otherwise healthy. The authors did not find any risk of arterial thrombosis.